Vanguard reports 3.06M shares of Delek US
Delek US Holdings Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,063,633 shares of Common Stock, equal to 5.12% of the class as reported.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Delek US Holdings Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,063,633 shares of Common Stock, equal to 5.12% of the class as reported. The filing shows sole voting power for 446,783 shares and sole dispositive power for 3,063,633 shares. The signature block is dated 04/29/2026.
Insights
Vanguard Capital Management reports a passive >5% stake in Delek US.
Schedule 13G lists Vanguard Capital Management as beneficial owner of 3,063,633 shares (5.12%), with dispositive control attributed to the reporting entity and affiliates. The disclosure indicates holdings include shares held for Vanguard funds and managed accounts.
Timing: the filing signature is 04/29/2026. Cash‑flow treatment or intended transactions are not stated in the excerpt.
The filing clarifies voting and dispositive authorities within Vanguard's reporting unit.
The filing specifies 446,783 shares with sole voting power and 3,063,633 shares with sole dispositive power, and notes affiliates exercise voting/dispositive power for certain managed accounts and Vanguard funds. No other single person is reported >5%.
Investors can use future filings to track changes to this position.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned regulatory
dispositive power financial
voting power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What voting power does Vanguard list for its Delek US stake?
Is another person reported as owning more than 5% of Delek US in this filing?
When was the Schedule 13G signed for this disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.